Independent predictors of improvement in HOMA score, systolic BP, weight, VEGF and EGF
| Biological variable (target reduction) | All study participants (n=141) | ||
| Covariate | OR | 95% CI | P values |
| HOMA score (reduction ≥20%) | |||
| Abstinence | 3.48 | 1.60 to 7.53 | 0.002 |
| Exercise+diet SLIQ score | 0.87 | 0.43 to 1.77 | 0.694 |
| Systolic BP (reduction ≥5%) | |||
| Abstinence | 6.47 | 2.71 to 15.46 | <0.001 |
| Exercise+diet SLIQ score | 1.47 | 0.70 to 3.08 | 0.310 |
| Weight (reduction ≥2%) | |||
| Abstinence | 15.63 | 3.54 to 68.95 | <0.001 |
| Exercise+diet SLIQ score | 0.74 | 0.323 to 1.69 | 0.475 |
| VEGF (reduction ≥20%) | |||
| Abstinence | 4.35 | 1.93 to 9.81 | <0.001 |
| Exercise+diet SLIQ score | 2.17 | 0.97 to 4.86 | 0.59 |
| EGF (reduction≥20%) | |||
| Abstinence | 48.81 | 15.26 to 156.06 | <0.001 |
| Exercise+diet SLIQ score | 2.52 | 0.80 to 7.95 | 0.115 |
Results are presented as adjusted odds ratios and 95% confidence intervals using multivariable logistic regression analysis.
SLIQ, Simple Lifestyle Indicator Questionnaire; EGF, epidermal growth factor; HOMA, homeostatic model assessment; VEGF, vascular endothelial growth factor.